Vancouver, B.C. – TheNewswire – May 25, 2021 – Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), (“Solarvest” or the “Company”), announces that its EverseaTM Inc. division has signed an agreement with MRF Associates Inc. to represent the Company in Brazil. Under the agreement MRF will use its extensive background and relationships to introduce SVS Organic Omega-3 products and ingredients into the Brazil marketplace.
MRF Associates Inc., (Principal, Dr. Michael Farley) has been working Brazil healthcare markets since 2003. In the natural products space, he advised Atrium Innovations (now Nestle) on market entry for several major brands, organized registration, distribution and clinical studies for an animal feed nutraceutical and is currently assisting a Sao Paulo supplement manufacturer to source full spectrum CBD oil tinctures. MRF is invested in a wellness clinic in Belo Horizonte focused on alternative treatments for chronic pain. In the 1990s Michael managed investment programs at the Canadian Foreign Affairs Department and was appointed Consul and Trade Commissioner in Milan, Italy. He holds a PhD in the Philosophy of Science from the Université de Montréal (1986).
Brazil (pop. 214 million) is the world’s 4th largest agriculture producer and a major market for plant based organics. 70 million Millennials (50% of the workforce) are driving demand for these products. 2019 data released by the Ministério da Agricultura (MAPA) reports $US 1 B+ in revenues for organic products growing at 15 % per annum.
Consumer awareness for Omega-3 products is high, with products offerings in supplement, functional food, natural product, vegan and wellness verticals. USDA organic imports are widely available in retail and online channels. “Brazil has a long tradition of plant derived health products and drugs, and is a significant market opportunity for SVS nutraceuticals”, says MRF. “We are looking forward to introducing the only certified organic Omega-3 to distributers and manufacturers in all verticals and growing market share effectively and rapidly”.
There is growing awareness among consumers for natural Omega-3 products free of production related chemicals, solvents, heavy metals and pollution as experienced in the baby food market. Organic marketers recognize the value of ocean plant-based, contaminant free production as a competitive advantage. The versatility of the patented ingredient has enabled the Company to demonstrate various organic Omega-3 products can be integrated into existing marketing channels. Moreover, in terms of intellectual property protection, the IP has been described as a rare commodity in this growing market segment.
SVS produces “clean label” products to satisfy demand for premium plant-based, organic Omega-3 health products. The company also offers manufacturers and retailers “private” and “white” label brands featuring our highly bioavailable Omega-3 ingredient. Market research shows strong demand for the product’s unique characteristics, particularly among consumers focused on organic and vegan diets. The Company’s patented Omega-3 active ingredient has been granted a FDA NDI (New Dietary Ingredient) and is USDA Organic and EU Organic Certified.
Solarvest BioEnergy Inc. is an algae biologics company whose production platform provides an extremely flexible system capable of producing numerous products from Omega 3 fatty acids to human therapeutic proteins. The company has successfully demonstrated the expression of BMP, a high value therapeutic protein, viral antigens (immune stimulating proteins), and Cecropins (antimicrobial peptide/protein). The company has initiated a program for the expression of CBD and THC to be produced in GMP fermentation facilities.
For further information contact:
Gerri Greenham, Chief Executive Officer
Phone: (647) 204-4095
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the terms of the Offering, the completion of the Offering and the expected use of the net proceeds received by the Company. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including but not limited to: general business, economic, competitive, geopolitical and social uncertainties; and regulatory risks. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The forward-looking information contained in this news release is expressly qualified in its entirety by this cautionary statement. The Company does not undertake to update any forward-looking information, except as required by applicable securities laws.
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.
None of the securities of Solarvest have been registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law, and may not be offered or sold in the United States or to, or for the account or benefit of, persons in the United States or “U.S. persons” (as such term is defined in Regulation S under the U.S. Securities Act) absent registration or an exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy in the United States nor shall there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful.